Legislation
- Title
- Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)
- Sponsored by
- Senators Lam, Beidle, Benson, Elfreth, Hayes, Jackson, King, Lee, Patterson, Pinsky, Washington, Augustine, Klausmeier, and Sydnor
- Status
- Vetoed by the Governor (Duplicative)
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Requiring insurers, nonprofit health service plans, and health maintenance organizations to limit the amount a covered individual is required to pay in copayments or coinsurance for a covered prescription insulin drug to not more than $30 for a 30-day supply.
Committees
Committee Testimony
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
15-822.1 )
Last Updated: 7/21/2022 11:47 AM